z-logo
Premium
Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway
Author(s) -
Chen Kunlun,
Gao Qing,
Zhang Wei,
Liu Zhongwei,
Cai Jiangyi,
Liu Ying,
Xu Jinkai,
Li Jie,
Yang Yi,
Xu Xin
Publication year - 2015
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.12458
Subject(s) - wnt signaling pathway , downregulation and upregulation , cell growth , cell cycle , cancer research , gene silencing , cell cycle checkpoint , gene knockdown , cell , biology , cell culture , viability assay , signal transduction , microbiology and biotechnology , chemistry , gene , genetics
Background & Aims Musashi1 (MSI1) belongs to the RNA‐binding protein (RBP) family, with functions as translational activator or suppressor of specifically bound mRNA . However, its function in hepatocellular carcinoma (HCC) has been deeply unexplored. Here, we investigated the role of MSI1 for proliferation and tumourigenesis in HCC. Methods The expression of MSI 1 in HCC tissues was examined by immunohistochemistry and western blotting. The effects of MSI 1 overexpression and silencing on cell proliferation, cell viability, tumoursphere and tumour formation of HCC were explored. Results In this study, we initially reported that MSI 1 was upregulated in HCC . Overexpression of MSI 1 in HepG2 cell lines resulted in significantly promoted cell growth, tumour formation and cell cycle progression. Consistently, knockdown of MSI 1 in Huh7 cell lines remarkably inhibited cell growth and tumour formation, and caused cell cycle arrest at the G1/S transition. Dual‐luciferase assays indicated that MSI 1 activated Wnt signal pathway, and APC and DKK 1 were direct targets of MSI 1. Conclusion Taken together, these findings indicate that an oncogenic role of MSI 1 in HCC may be through modulation of cell growth and cell cycle by activating Wnt pathway via direct downregulation of APC and DKK 1.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here